Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice / Michael S. Ritsner en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 6 (Diciembre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 6 (Diciembre) . - PP. 582-591 Título : Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice : A naturalistic comparative study Tipo de documento: texto impreso Autores: Michael S. Ritsner, Autor ; Anatoly Gibel, Autor ; Galina Perelroyzen, Autor Fecha de publicación: 2023 Artículo en la página: PP. 582-591 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Atención Ambulatoria, Antipsicóticos, Benzodiacepinas, Calidad de Vida, Risperidona, Esquizofrenia, Psicología esquizofrénica. Resumen: Findings in previous studies investigating the beneficial effect of risperidone and olanzapine versus typical antipsychotics on quality of life (QOL) are controversial since they did not adjust for various factors contributing to QOL. To test this assumption in a naturalistic cross-sectional design, we evaluated general and domain-specific QOL scores for baseline data of schizophrenia outpatients stabilized on atypical (N = 78, risperidone or olanzapine) and typical (N = 55) agents. Link: ./index.php?lvl=notice_display&id=30929 [artículo] Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice : A naturalistic comparative study [texto impreso] / Michael S. Ritsner, Autor ; Anatoly Gibel, Autor ; Galina Perelroyzen, Autor . - 2023 . - PP. 582-591. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 6 (Diciembre) . - PP. 582-591 Palabras clave: Atención Ambulatoria, Antipsicóticos, Benzodiacepinas, Calidad de Vida, Risperidona, Esquizofrenia, Psicología esquizofrénica. Resumen: Findings in previous studies investigating the beneficial effect of risperidone and olanzapine versus typical antipsychotics on quality of life (QOL) are controversial since they did not adjust for various factors contributing to QOL. To test this assumption in a naturalistic cross-sectional design, we evaluated general and domain-specific QOL scores for baseline data of schizophrenia outpatients stabilized on atypical (N = 78, risperidone or olanzapine) and typical (N = 55) agents. Link: ./index.php?lvl=notice_display&id=30929

---

1 (1 - 1 / 1)